Cargando…
Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Via Medica
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890410/ https://www.ncbi.nlm.nih.gov/pubmed/34931694 http://dx.doi.org/10.5603/CJ.a2021.0169 |
| _version_ | 1784661631978962944 |
|---|---|
| author | Martín, Ernesto Castillo, Juan C. González-Manzanares, Rafael López-Aguilera, José Perea, Jorge Anguita, Manuel |
| author_facet | Martín, Ernesto Castillo, Juan C. González-Manzanares, Rafael López-Aguilera, José Perea, Jorge Anguita, Manuel |
| author_sort | Martín, Ernesto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8890410 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Via Medica |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88904102022-03-03 Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? Martín, Ernesto Castillo, Juan C. González-Manzanares, Rafael López-Aguilera, José Perea, Jorge Anguita, Manuel Cardiol J Clinical Cardiology Via Medica 2022-02-23 /pmc/articles/PMC8890410/ /pubmed/34931694 http://dx.doi.org/10.5603/CJ.a2021.0169 Text en Copyright © 2022 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially |
| spellingShingle | Clinical Cardiology Martín, Ernesto Castillo, Juan C. González-Manzanares, Rafael López-Aguilera, José Perea, Jorge Anguita, Manuel Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? |
| title | Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? |
| title_full | Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? |
| title_fullStr | Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? |
| title_full_unstemmed | Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? |
| title_short | Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? |
| title_sort | does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure? |
| topic | Clinical Cardiology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890410/ https://www.ncbi.nlm.nih.gov/pubmed/34931694 http://dx.doi.org/10.5603/CJ.a2021.0169 |
| work_keys_str_mv | AT martinernesto doescanagliflozindecreasenatriureticpeptidelevelsinpatientswithdiabetesandheartfailure AT castillojuanc doescanagliflozindecreasenatriureticpeptidelevelsinpatientswithdiabetesandheartfailure AT gonzalezmanzanaresrafael doescanagliflozindecreasenatriureticpeptidelevelsinpatientswithdiabetesandheartfailure AT lopezaguilerajose doescanagliflozindecreasenatriureticpeptidelevelsinpatientswithdiabetesandheartfailure AT pereajorge doescanagliflozindecreasenatriureticpeptidelevelsinpatientswithdiabetesandheartfailure AT anguitamanuel doescanagliflozindecreasenatriureticpeptidelevelsinpatientswithdiabetesandheartfailure |